Nevertheless, there is some evidence to suggest that the incidence of stroke and the progression of CKD may be controlled using more focused FA therapy (baseline FA levels may affect the effectiveness of the FA intervention therapy), particularly in people with the MTHFR 677TT genotype, low to moderate levels of folate, and in nations without a grain fortification program. This evidence concerns the gene MTHFR and chronic kidney disease.